Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.8120
+0.0510 (6.70%)
May 23, 2025, 4:00 PM - Market closed
MTNB Market Cap
MTNB has a market cap or net worth of $4.13 million as of May 23, 2025. Its market cap has decreased by -89.30% in one year.
Market Cap
4.13M
Enterprise Value
-79.37K
1-Year Change
-89.30%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since March 2, 2017, MTNB's market cap has decreased from $223.50M to $4.13M, a decrease of -98.15%. That is a compound annual growth rate of -38.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 4.10M | 57.69% |
| Dec 31, 2024 | 2.60M | -94.47% |
| Dec 29, 2023 | 47.00M | -56.64% |
| Dec 30, 2022 | 108.40M | -50.37% |
| Dec 31, 2021 | 218.40M | -19.41% |
| Dec 31, 2020 | 271.00M | -26.64% |
| Dec 31, 2019 | 369.40M | 452.17% |
| Dec 31, 2018 | 66.90M | -37.94% |
| Dec 29, 2017 | 107.80M | -51.77% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.81B |
| Johnson & Johnson | 368.56B |
| AbbVie | 321.13B |
| Novo Nordisk | 308.07B |
| UnitedHealth Group | 274.85B |
| Abbott Laboratories | 231.49B |
| Novartis AG | 222.59B |
| AstraZeneca | 218.71B |